sample	score	sd	N	CI	ext_ID	timepoint	Age	cancer_status	previous_cancer	stage	cancer_type	ichor	slope	days
TGL49_0022_Cf_U_PE_310_WG	-0.083491292	0.355138146	35	0.121994222	LFS3	5	Pediatric	Negative	Yes	none	NA	0	-0.893466978	48.32876712
TGL49_0022_Cf_U_PE_315_WG	0.809975686	0.22727181	25	0.093813192	LFS3	4	Pediatric	Negative	Yes	none	NA	0	0.507763112	41.42465753
TGL49_0022_Cf_U_PE_316_WG	8.52E-18	0.351946717	26	0.142154355	LFS3	0	Pediatric	Negative	No	none	NA	0.04096	0	0
TGL49_0022_Cf_U_PE_317_WG	0.302212574	0.28525272	100	0.056600328	LFS3	3	Pediatric	Positive	No	Stage 0/I/II	Glioma	0	0.004515457	38.6630137
TGL49_0022_Cf_U_PE_320_WG	0.43801171	0.233631703	28	0.090592917	LFS3	1	Pediatric	Negative	No	none	NA	0	0.43801171	35.2109589
TGL49_0022_Cf_U_PE_322_WG	0.297697117	0.271049687	100	0.053782138	LFS3	2	Pediatric	Positive	No	Stage 0/I/II	Glioma	0	-0.140314593	37.90684932
TGL49_0022_Pb_n_PE_305_WG	0.156924527	0.196126044	28	0.076049741	LFS3	7	Pediatric	Negative	Yes	none	NA	0	0.240415819	65.12876712
TGL49_0022_Pb_n_PE_306_WG	0.195873567	0.293092451	25	0.120982618	LFS3	8	Pediatric	Negative	Yes	none	NA	0	0.03894904	73.41369863
TGL49_0022_Pb_n_PE_307_WG	0.275198436	0.342264609	27	0.13539537	LFS3	9	Pediatric	Negative	Yes	none	NA	0	0.079324868	82.32328767
TGL49_0022_Pb_n_PE_427_WG	0.211045502	0.237937	100	0.047211863	LFS3	10	Pediatric	Positive	Yes	Stage III/IV	Osteosarcoma	0.02829	-0.064152934	85.97260274
TGL49_0025_Cf_U_PE_310_WG	-0.267860261	0.328084233	26	0.13251609	LFS5	3	Pediatric	Negative	Yes	none	NA	0	-0.445058018	42.80547945
TGL49_0025_Cf_U_PE_313_WG	3.17E-17	0.314171107	100	0.062338364	LFS5	0	Pediatric	Positive	Yes	Stage 0/I/II	Glioma	0	0	0
TGL49_0025_Cf_U_PE_316_WG	0.40147933	0.253664299	31	0.093044816	LFS5	5	Pediatric	Negative	Yes	none	NA	0	0.072408675	51.55068493
TGL49_0025_Cf_U_PE_317_WG	0.177197757	0.307961771	21	0.140182517	LFS5	2	Pediatric	Negative	Yes	none	NA	0	0.177197757	12.19726027
TGL49_0025_Cf_U_PE_322_WG	0.329070656	0.301400803	27	0.119230187	LFS5	4	Pediatric	Negative	Yes	none	NA	0	0.596930917	48.32876712
TGL49_0025_Pb_n_PE_309_WG	0.660793604	0.238823176	100	0.047387699	LFS5	6	Pediatric	Positive	Yes	Stage III/IV	Osteosarcoma	0.03846	0.259314273	57.53424658
TGL49_0025_Pb_n_PE_311_WG	0.002654697	0.287607292	38	0.094534164	LFS5	7	Pediatric	Negative	Yes	none	NA	0	-0.658138907	66.73972603
TGL49_0025_Pb_n_PE_421_WG	-0.073442254	0.296495283	23	0.128214175	LFS5	8	Pediatric	Negative	Yes	none	NA	0	-0.076096951	79.03561644
TGL49_0034_Cf_n_PE_412_WG	-0.319845134	0.280561428	21	0.127710031	LFS40	2	Adult	Negative	Yes	none	NA	0	-0.691439487	13.11780822
TGL49_0034_Cf_n_PE_619_WG	0.13866486	0.25601795	33	0.090780018	LFS40	3	Adult	Negative	Yes	none	NA	0	0.458509994	24.16438356
TGL49_0034_Cf_U_PE_308_WG	3.89E-17	0.243663884	100	0.048348201	LFS40	0	Adult	Positive	Yes	Stage III/IV	Sarcoma	0	0	0
TGL49_0319_Cf_n_PE_383_WG	0.371594353	0.18187487	24	0.076799022	LFS40	1	Adult	Negative	Yes	none	NA	0	0.371594353	5.983561644